Online doctor consulting platform DocsApp raises $20 million, announces merger with Medibuddy

DocsApp announced merger with cashless digital healthcare platform Medibuddy for an undisclosed amount.

June 04, 2020 / 02:05 PM IST
FILE -- Dr. Paul Casey makes a video call at Rush University Medical Center in Chicago on March 6, 2020. Amid the uncertainty swirling around the coronavirus pandemic some experts recommend that older adults at risk cancel nonessential doctor’s appointments, including wellness visits, instead to consider using Telemedicine sessions, if available, as a reasonable substitute. (Danielle Scruggs/The New York Times)

FILE -- Dr. Paul Casey makes a video call at Rush University Medical Center in Chicago on March 6, 2020. Amid the uncertainty swirling around the coronavirus pandemic some experts recommend that older adults at risk cancel nonessential doctor’s appointments, including wellness visits, instead to consider using Telemedicine sessions, if available, as a reasonable substitute. (Danielle Scruggs/The New York Times)

Online doctor consultation provider DocsApp on June 4 said it has raised around $20 million in Series-B from venture capital (VC) investors in the US and Japan.

This investment also includes last month's fundraising of $9.6 million. In the latest fundraise, Bessemer Venture Partners, Fusion Capital, Mitsui Sumitomo and Beyond Next Ventures have invested, along with existing investors Rebright Partners and Milliways Ventures.

Bessemer Venture Partners and Fusion Capital pitched $5 million each in Series-B round of funding.

"We will be using the funds to strengthen doctor base, expand patient reach and invest on technologies and services," said Satish Kannan, Co-founder & CEO, DocsApp.

Kannan and Enbasekar Dinadayalane will maintain controlling stake post fundraising.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Merger with Medibuddy

DocsApp announced a merger with cashless digital healthcare platform Medibuddy for an undisclosed amount. The merger will be in a cash-and-stock deal. Both brands will continue to exist independently.

Kannan said the joint entity will cater to the needs of 3 crore consumers with 90,000 registered doctors, 7,000 hospitals, 3,000 labs and 2,500 pharmacies on the platform.

Kannan said post-merger, they will be able to service 95 percent of pin-codes. Currently, 50 percent of customers of DocsApp are from small towns and rural areas.

COVID-19 boost to telemedicine

DocsApp is one of the big beneficiaries of COVID-19, as more people are consulting doctors online.

Kannan said online consultations on his platform jumped 60 percent jump over the last two months.

It's not just patients, even doctors and hospitals are now coming on board to make themselves accessible to patients.

Kannan said the government announcement of telemedicine guidelines has given confidence to doctors and hospitals.

Telemedicine guidelines have clarified on consent and technology applications that constitute telemedicine. Telemedicine includes video calling, chat platforms like WhatsApp, Facebook Messenger, among others, or Mobile App or internet-based digital platforms like Skype, email and fax.

Every day DocsApp does about 25,000 consults. The company says about 70 percent of the traffic on its platform is related to consultation and the rest is for medicines and diagnostics.

Bengaluru-based DocsApp was established by IITians, Kannan and Dinadayalane in 2015.
Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.
first published: Jun 4, 2020 02:05 pm

stay updated

Get Daily News on your Browser
Sections